期刊文献+

PTPN12与非小细胞肺癌放射敏感性的关系研究 被引量:4

Effect of protein tyrosine phosphatase non-receptor type 12(PTPN12) downregulation on the radiosensitivity of non-small cell lung cancer
下载PDF
导出
摘要 目的:探讨非小细胞肺癌(non-small cell lung cancer,NSCLC)组织中非受体型蛋白酪氨酸磷酸酶12(protein tyrosine phosphatase non-receptor type 12,PTPN12)表达与放疗疗效的关系,评估PTPN12基因下调与H1299细胞放射敏感性的关系。方法:回顾性分析2013年9月至2014年10月河北医科大学第四医院92例接受根治性放疗的NSCLC患者的临床资料,通过免疫组织化学方法检测肿瘤组织中PTPN12的表达,并分析其与患者放疗疗效的关系。通过shRNA-PTPN12干扰质粒转染H1299细胞,利用实时定量PCR技术及Western blot技术检测PTPN12在mRNA及蛋白水平的表达。通过克隆形成实验构建细胞生存曲线,评估PTPN12基因下调对H1299细胞放射敏感性的作用。结果:PTPN12低表达患者的放疗疗效明显优于高表达者(80.0%vs.57.1%,P=0.018)。多因素分析显示PTPN12表达是影响放疗疗效的唯一因素。构建shRNA-GFP及shRNA-PTPN12干扰质粒转染H1299细胞,获得稳定转染细胞株H1299-shGFP及H1299-shPTPN12。细胞生存曲线显示H1299-shGFP及H1299-shPTPN12细胞的D0、Dq、SF2值分别为3.02 Gy、3.41 Gy、0.94及1.81 Gy、2.40 Gy、0.72,具有显著性差异(P<0.05)。结论:PTPN12低表达与NSCLC患者的放疗疗效密切相关,而PTPN12基因下调能明显增加H1299细胞的放射敏感性。 Objective: To identify the relationship between the expression of protein tyrosine phosphatase non- receptor type 12(PTPN12) and radiotherapy effect in non-small cell lung cancer(NSCLC) tissues and to determine whether PTPN12 deficiency can sensitize lung cancer cells to irradiation. Methods: From September 2013 to October 2014, 92 NSCLC patients undergoing radiotherapy with or without platinum-based combination chemotherapy were analyzed retrospectively. Before the treatment, PTPN12 expression was detected through immunohistochemistry. After the completion of radiotherapy, the patients’ responses were assessed and radiotherapeutic efficacy analyzed. The human NSCLC cell line H1299 was infected with sh PTPN12 knockdown, and colony survival assay was analyzed after irradiation. Chi-square test was used to examine the correlation between PTPN12 expression and clinicopathological characteristics. Univariate analyses and Logistic regression test were used to analyze the relationship between clinicopathological characteristics and radiotherapeutic response. Results: Patients with low PTPN12 expression were more sensitive to radiotherapy than those with high PTPN12 expression(80.0% vs. 57.1%, P=0.018). Multivariate analysis showed that PTPN12 expression was the only independent predictor of radiotherapeutic response in NSCLC. The H1299-sh PTPN12-knockdown cells were sensitive to irradiation.Conclusions: The results of the study indicated that downregulation of PTPN12 improved the radiosensitivity of NSCLC cells.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2016年第7期285-290,共6页 Chinese Journal of Clinical Oncology
关键词 PTPN12 非小细胞肺癌 放疗疗效 H1299细胞 放射敏感性 PTPN12 non-small cell lung cancer radiotherapeutic efficacy H1299 cell line radiosensitivity
  • 相关文献

参考文献19

  • 1Siegel R,Miller KD,Jemal A.Cancer statistics 2015[J].CA Cancer JClin,2015,65(1):5-29.
  • 2Saadeddin A.Radiotherapy for NSCLC:review of conventional and new treatment technique[J].J Infect Public Health,2012,1:S45-49.
  • 3Lu Z,Hunter T.Degradation of activated protein kinases by ubiquitination[J].Annu Rev Biochem,2009,78:435-475.
  • 4Sun T,Aceto N,Meerbrey KL,et al.Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12phosphatase[J].Cell,2011,144(5):703-718.
  • 5Cao X,Li Y,Luo RZ,et al.Tyrosine-Protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma[J].Ann Thorac Surg,2012,93(5):1674-1680.
  • 6Espejo R,Rengifo-Cam W,Schaller MD,et al.PTP-PEST controls motility,adherens junction assembly,and Rho GTPase activity in colon cancer cells[J].Am J Physiol Cell Physiol,2010,299(2):C454-463.
  • 7Rami-Porta R,Crowley JJ,Goldstraw P.The revised TNM staging system for lung cancer[J].Ann Thorac Cardiovasc Surg,2009,15(1):4-9.
  • 8Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors.European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States,National Cancer Institute of Canada[J].JNatl Cancer Inst,2000,92(3):205-216.
  • 9Eisenhauer EA,Therasse P,Bogaerts J,et al.New response evaluation criteria in solid tumours:revised RECIST guideline(version 1.1)[J].Eur J Cancer,2009,45(2):228-247.
  • 10Galgano MT,Hampton GM,Frierson HF Jr.Comprehensive analysis of HE4 expression in normal and malignant human tissues[J].Mod Pathol,2006,19(6):847-853.

同被引文献33

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部